Pulmatrix Inc. (PULM)
NASDAQ: PULM
· Real-Time Price · USD
6.24
0.04 (0.65%)
At close: May 12, 2025, 3:42 PM
6.40
2.56%
After-hours: May 12, 2025, 05:05 PM EDT
Pulmatrix Revenue Breakdown
| Period Ending | Dec 31, 2020 |
|---|---|
| Toxicology Study Costs Revenue | 1.65M |
| Toxicology Study Costs Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.95M | 2.21M | 1.89M | 1.41M | 741K | 1.73M | 1.67M | 2.21M | 1.57M | 1.69M | 1.55M | 1.97M | 1.54M | 1.66M | 1.56M | 1.62M | 1.41M | 1.78M | 1.49M | 2.21M | 1.59M | 1.78M | 3.13M | 1.99M | 1.59M | 1.77M | 2.12M | 2.05M | 1.84M | 2.02M | 2.07M | 1.64M | 1.84M | 1.55M | 2.21M | 2.41M | 2.1M | 3.12M | 9.88M | 1.3M |
| Selling, General, and Administrative Revenue Growth | -11.77% | +17.06% | +33.73% | +90.42% | -57.14% | +3.53% | -24.43% | +41.12% | -7.06% | +8.50% | -21.33% | +28.18% | -7.00% | +6.02% | -3.52% | +14.90% | -20.66% | +19.19% | -32.64% | +39.21% | -10.98% | -42.93% | +57.42% | +25.13% | -10.23% | -16.36% | +3.37% | +11.20% | -8.96% | -2.18% | +25.98% | -10.97% | +18.84% | -29.99% | -8.09% | +14.55% | -32.57% | -68.43% | +657.59% | n/a |
| Research and Development Revenue | 6K | 814K | 2.79M | 3.45M | 3.48M | 3.96M | 4.17M | 3.87M | 4.47M | 5.29M | 4.34M | 4.15M | 2.96M | 4.03M | 4.54M | 3.86M | 3.27M | 3.87M | 3.18M | 5.29M | 4.21M | 3.3M | 3.16M | 2.18M | 2.68M | 3.06M | 4.01M | 3.22M | 2.59M | 2.62M | 3.36M | 1.67M | 2.77M | 1.51M | 2.44M | 3.43M | 2.47M | 2.19M | 1.61M | 254K |
| Research and Development Revenue Growth | -99.26% | -70.79% | -19.29% | -0.72% | -12.24% | -4.85% | +7.51% | -13.28% | -15.51% | +21.90% | +4.53% | +40.22% | -26.50% | -11.34% | +17.76% | +18.10% | -15.70% | +21.64% | -39.78% | +25.64% | +27.63% | +4.20% | +45.40% | -18.68% | -12.43% | -23.85% | +24.59% | +24.41% | -1.11% | -22.15% | +101.14% | -39.73% | +84.07% | -38.26% | -28.83% | +39.09% | +12.45% | +36.21% | +533.86% | n/a |